Regulus Therapeutics Inc (NASDAQ:RGLS)

Wednesday’s trading has closed, but RGLS is being traded in the after-hours session. After-Hours quote »
17.45
Delayed Data
As of 3:59pm ET
 +0.51 / +3.01%
Today’s Change
5.40
Today|||52-Week Range
25.60
+8.79%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close16.94
Today’s open16.76
Day’s range16.25 - 17.49
Volume519,104
Average volume (3 months)692,308
Market cap$855.8M
Dividend yield--
Data as of 3:59pm ET, 04/01/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+19.68%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book6.28

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.28+1.17%
OMEROmeros Corp-0.08-0.36%
TKMRTekmira Pharmaceutic...+0.09+0.52%
OMEDOncoMed Pharmaceutic...+0.14+0.54%
Data as of 4:00pm ET, 04/01/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account